Skip to content

Migration of the CapFlex-PIP implant system for proximal interphalangeal joint arthroplasy: a 10 year follow up RSA study

Migration of the CapFlex-PIP implant system for proximal interphalangeal joint arthroplasy: a 10 year follow up RSA study - Capflex RSA

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON53919
Enrollment
36
Registered
2022-04-28
Start date
2023-10-25
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

degenerative joint disease, Osteoarthritis Osteoarthritis

Interventions

None listed

Sponsors

Reinier Haga Orthopedisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Indication for PIP joint arthroplasty as described in the manufacturer's guideline, namely as a result of: Painfull osteoarthritis or instable communitive intra-articular PIP fractures- Age > 18 years- Patient is able to speak and write Dutch- Patient is willing to participate- Patient is able and willing to provide written informed consent

Exclusion criteria

Exclusion criteria: - Inflammatory arthritis with significant bone loss - Insufficient bone quality to provide adequate stability - Known or suspected sensitivity or allergy to one or more of the implant materials - Revision surgery - Significant collateral instability - Pregnancy

Design outcomes

Primary

MeasureTime frame
The main study parameters are the migration of the CapFlex PIP implant system of the distal as well as the proximal component (presented in x-, y- and z-direction). Furthermore, the stability of the markers will be determined and the complications due to the markers and/or marker inserter will be registered.

Secondary

MeasureTime frame
Secondary study parameters are the survival of the CapFlex PIP implant system, clinical scores and radiographic aspects.

Countries

Netherlands

Contacts

Public ContactN.M.C. Mathijssen

Reinier Haga Orthopedisch Centrum

Onderzoek@rhoc.nl079 206 5595

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 20, 2026